Beqvez was Pfizer's first gene therapy, stemming from an alliance with Spark Therapeutics (now part of Roche) more than a ...

Here's why a gene therapy product originally developed at CHOP spinout Spark Therapeutics was shelved by Pfizer.

US pharma giant Pfizer has ended all development and commercialization activities relating to fidanacogene elaparvovec, a ...

点击蓝字，关注我们声明个人观点 · 不代表任何组织与单位欢迎来到Y博说医解药，我们关注医药前沿，力争把复杂议题、热点突破解释明白。2025年2月21日，辉瑞宣布将中止商业化去年刚获得FDA批准的B型血友病治疗药物Beqvez（fidanacogene ...